Olivier Boyé

Statistics

Publications

Citations

304

H-Index

Active since

1989

Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases(Current)

National Institutes of Health

National Cancer Institute

Olivier Boyé is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in drug binding sites on tubulin, microtubule-associated proteins, and medicinal chemistry.

Publications per year

1989–2005

Publications

Identification of Cysteine 354 of β-Tubulin as Part of the Binding Site for the A Ring of Colchicine

Ruoli Bai, Xue‐Feng Pei, Olivier Boyé et al. · Journal of Biological Chemistry · 1996 · 159 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

aS,7S‐absolute configuration of natural (−)‐colchicine and allocongeners

Arnold Brossi, Olivier Boyé, Anjum Muzaffar et al. · FEBS Letters · 1990 · 41 citations · Full text

Life Sciences, Biochemistry, Chemistry +9

Natural products. Antitubulin effect of congeners of <i>N</i>-acetylcolchinyl methyl ether: synthesis of optically active 5-acetamidodeaminocolchinyl methyl ether and of demethoxy analogues of deaminocolchinyl methyl ether

Olivier Boyé, A. BROSSI, Herman J. C. Yeh et al. · Canadian Journal of Chemistry · 1992 · 30 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Deaminocolchinyl Methyl Ether: Synthesis from 2,3,4,4′‐Tetramethoxybiphenyl‐2‐carbaldehyde. Comparison of antitubulin effects of deaminocolchinyl methyl ether and dehydro analogs

Olivier Boyé, Yoshikuni Itoh, Arnold Brossi · Helvetica Chimica Acta · 1989 · 23 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Synthesis of Tricyclic Phenylpyrrole Lactams, New Models of Antitubulin Agents

J.‐P. ALAZARD, Corine Millet-Paillusson, Olivier Boyé et al. · Bioorganic & Medicinal Chemistry Letters · 1991 · 20 citations

Pharmacy, Medicinal Chemistry, Pharmacology +9

1–5 of 7